摘要
目的分析处方中存在的重复用药假阳性问题,针对性完善重复用药的审核机制,为提高处方审核质量提供参考。方法以华中科技大学同济医学院附属同济医院“PASS处方审核系统”的审核机制和基础审核知识库为基础,明确重复用药的概念,完善重复用药审核机制并进一步精细审核规则。结果完善后的重复用药处方审核机制能适应临床用药的复杂性,既可分辨重复用药问题,又能保证临床合理联合用药。结论精细化用药处方审核机制能识别重复用药假阳性问题,减少重复用药假阳性问题给临床诊疗造成的阻碍,提高了处方审核的质量和效率。
Objective The false positive problems of repeated drug use were analyzed to improve the review mechanism of repeated drug uses,so as to provide a reference for improving the quality of prescription review.Methods Based on the review mechanism of"PASS Prescription Audit System"and the basic audit knowledge database of Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,the concept of repeated drug use was clarified,and the review mechanism of repeated drug use was improved and the review rules were further refined.Results The improved review mechanism of repeated drug prescription can adapt to the complexity of clinical drug use,which can not only identify the problem of reuse,but also ensure rational clinical combination of drug use.Conclusion The refined drug prescription review mechanism can identify false positive problems of repeated drug use,reduce the obstacles caused by false positive problems of repeated drug use to clinical diagnosis and treatment,and improve the quality and efficiency of prescription drug review.
作者
李为
刘宇
郭敏
刘金玉
刘秀兰
曾露
刘东
李娟
LI Wei;LIU Yu;GUO Min;LIU Jinyu;LIU Xiulan;ZENG Lu;LIU Dong;LI Juan(Department of Pharmacy,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处
《医药导报》
CAS
北大核心
2021年第12期1757-1760,共4页
Herald of Medicine
基金
国家重点研发计划资助项目(2020YFC2009001)。
关键词
重复用药
处方审核
PASS处方审核系统
Repeat medication
Prescription review
PASS prescription review system